Tumor lysis syndrome: current perspective

被引：82

作者：

Hochberg, Jessica ^{[1
]}

Cairo, Mitchell S. ^{[1
]}

机构：

[1] Columbia Univ, New York Presbyterian, Morgan Stanley Childrens Hosp, New York, NY 10027 USA

来源：

HAEMATOLOGICA | 2007年 / 93卷 / 01期

关键词：

D O I：

10.3324/haematol.12327

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Successful management and treatment of tumor lysis syndrome is highly dependent on the prompt identication of clinical and laboratory characteristics, signs and symptoms of patients at risk. Establishment of vascular access and the initiation of prophylactic measures, especially hydration and administration of allopurinol or rasburicase, are vital. The early recognition and treatment of metabolic abnormalities usually prevents the severe and life-threatening complications associated with tumor lysis syndrome.

引用

页码：9 / 13

页数：5

共 37 条

[1]

Agha-Razii M, 2000, CLIN NEPHROL, V54, P59

[2] Tumor lysis syndrome after treatment with docetaxel for non-small-cell lung cancer [J].

Ajzensztejn, D ;

Hegde, VS ;

Lee, SM .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) :2389-2391

[3] Tumor lysis syndrome in children with non-Hodgkin lymphoma [J].

Alavi, S ;

Arzanian, MT ;

Abbasian, MR ;

Ashena, Z .

PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2006, 23 (01) :65-70

[4] PURINE EXCRETION DURING TUMOR LYSIS IN CHILDREN WITH ACUTE LYMPHOCYTIC-LEUKEMIA RECEIVING ALLOPURINOL - RELATIONSHIP TO ACUTE-RENAL-FAILURE [J].

ANDREOLI, SP ;

CLARK, JH ;

MCGUIRE, WA ;

BERGSTEIN, JM .

JOURNAL OF PEDIATRICS, 1986, 109 (02) :292-298

[5] Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin's lymphoma in four European countries [J].

Annemans, L ;

Moeremans, K ;

Lamotte, M ;

Conde, JG ;

Van den Berg, H ;

Myint, H ;

Pieters, R ;

Uyttebroeck, A .

LEUKEMIA & LYMPHOMA, 2003, 44 (01) :77-83

[6] AMERICAN BURKITTS-LYMPHOMA - CLINICOPATHOLOGIC STUDY OF 30 CASES .1. CLINICAL FACTORS RELATING TO PROLONGED SURVIVAL [J].

ARSENEAU, JC ;

CANELLOS, GP ;

BANKS, PM ;

BERARD, CW ;

GRALNICK, HR ;

DEVITA, VT .

AMERICAN JOURNAL OF MEDICINE, 1975, 58 (03) :314-321

[7]

Barquero Romero J, 2005, AN MED INT, V22, P387

[8] Rasburicase: A new approach for preventing and/or treating tumor Lysis syndrome [J].

Bessmertny, O ;

Robitaille, LM ;

Cairo, MS .

CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (32) :4177-4185

[9] Tumour lysis syndrome: new therapeutic strategies and classification [J].

Cairo, MS ;

Bishop, M .

BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (01) :3-11

[10]

Cairo MS, 2002, ASCO P, V21, P271

← 1 2 3 4 →